Advertisement
Screener

OPTIMER PHARMACEUTICALS INC Costs and Expenses

OPTIMER PHARMACEUTICALS INC Costs and Expenses

OPTIMER PHARMACEUTICALS INC reported Costs and Expenses of $47.19 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:CostsAndExpenses · last filed 2013-08-07

  • OPTIMER PHARMACEUTICALS INC costs and expenses for the quarter ending 2013-06-30 was $47.19M, a 4.53% decline year-over-year.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for the quarter ending 2013-03-31 was $50.93M, a 4.02% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for the quarter ending 2012-12-31 was $49.84M, a 3.91% decline year-over-year.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for the quarter ending 2012-09-30 was $44.15M, a 16.28% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for fiscal 2012 was $192.37M, a 38.06% increase from fiscal 2011.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for fiscal 2011 was $139.34M, a 176.75% increase from fiscal 2010.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for fiscal 2010 was $50.35M, a 15.77% increase from fiscal 2009.
  • OPTIMER PHARMACEUTICALS INC costs and expenses for fiscal 2009 was $43.49M.
Period endCosts and Expenses 3 monthCosts and Expenses 3 month as first filedCosts and Expenses 6 monthCosts and Expenses 9 monthCosts and Expenses 12 month
2013-06-30$47.19M
10-Q · filed 2013-08-07
$98.11M
10-Q · filed 2013-08-07
$147.95M
derived: sum of 3 quarters · filed 2013-08-07
$192.10M
derived: sum of 4 quarters · filed 2013-08-07
2013-03-31$50.93M
10-Q · filed 2013-05-10
$100.76M
derived: sum of 2 quarters · filed 2013-05-10
$144.91M
derived: sum of 3 quarters · filed 2013-05-10
$194.34M
derived: sum of 4 quarters · filed 2013-08-07
2012-12-31$49.84M
10-K · filed 2013-03-18
$93.98M
derived: sum of 2 quarters · filed 2013-03-18
$143.41M
derived: sum of 3 quarters · filed 2013-08-07
$192.37M
10-K · filed 2013-03-18
2012-09-30$44.15M
10-K · filed 2013-03-18
$44.15M
10-Q · filed 2012-11-02
$93.58M
derived: sum of 2 quarters · filed 2013-08-07
$142.53M
10-Q · filed 2012-11-02
$194.40M
derived: sum of 4 quarters · filed 2013-08-07
2012-06-30$49.43M
10-Q · filed 2013-08-07
$98.39M
10-Q · filed 2013-08-07
$150.25M
derived: sum of 3 quarters · filed 2013-08-07
$188.22M
derived: sum of 4 quarters · filed 2013-08-07
2012-03-31$48.96M
10-Q · filed 2013-05-10
$100.82M
derived: sum of 2 quarters · filed 2013-05-10
$138.79M
derived: sum of 3 quarters · filed 2013-05-10
$163.84M
derived: sum of 4 quarters · filed 2013-05-10
2011-12-31$51.86M
10-K · filed 2013-03-18
$89.83M
derived: sum of 2 quarters · filed 2013-03-18
$114.88M
derived: sum of 3 quarters · filed 2013-03-18
$139.34M
10-K · filed 2013-03-18
2011-09-30$37.97M
10-K · filed 2013-03-18
$37.97M
10-Q · filed 2011-11-03
$63.02M
derived: sum of 2 quarters · filed 2013-03-18
$87.48M
10-Q · filed 2012-11-02
$100.12M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$25.05M
10-K · filed 2013-03-18
$25.05M
10-Q · filed 2011-08-04
$49.51M
10-Q · filed 2012-08-03
$62.16M
derived: sum of 3 quarters · filed 2013-03-18
$75.08M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$24.46M
10-K · filed 2013-03-18
$24.46M
10-Q · filed 2012-05-10
$37.11M
derived: sum of 2 quarters · filed 2013-03-18
$50.03M
derived: sum of 3 quarters · filed 2013-03-18
$60.79M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$12.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$25.57M
derived: sum of 2 quarters · filed 2013-03-18
$36.33M
derived: sum of 3 quarters · filed 2013-03-18
$50.35M
10-K · filed 2013-03-18
2010-09-30$12.92M
10-Q · filed 2011-11-03
$23.68M
derived: sum of 2 quarters · filed 2011-11-03
$37.70M
10-Q · filed 2011-11-03
2010-06-30$10.76M
10-Q · filed 2011-08-04
$24.78M
10-Q · filed 2011-08-04
2009-12-31$43.49M
10-K · filed 2012-03-08